Literature DB >> 8231582

Partial cricoid resection with primary tracheal anastomosis for subglottic stenosis in infants and children.

P Monnier1, M Savary, G Chapuis.   

Abstract

Fifteen infants and children with a severe subglottic stenosis underwent a partial cricoid resection with primary tracheal anastomosis. The etiology of the stenosis was congenital in 3 cases and was acquired after prolonged intubation in 12. Fourteen patients were tracheotomy dependent at the time of surgery, and 13 (87%) of the 15 were classified grade III (7 cases) and IV (6 cases) according to Cotton. The resection included the cricoid only in 5 cases and the cricoid and a segment of trachea (1 to 4 rings) in 10 cases. Decannulation was achieved after a single open procedure in 14 (93%) of the cases. The authors encountered no lesion of the recurrent laryngeal nerves and no fatalities. There was, however, 1 restenosis. Twelve cases were decannulated within 6 months, most of them at 2 months. The postoperative voice is normal in 10 cases, and a slight dysphonia is present in 4 cases. Twelve patients show no exertional dyspnea, and 2 exhibit a slight stridor while practicing sports. Ten of 14 cases have been followed for more than 5 years, with the longest follow-up now being 14 years. In all cases, the laryngotracheal development is normal. The results of this small series compare favorably with those of laryngotracheoplasty procedures usually performed for subglottic stenosis in infants and children. In the future, partial cricoid resection with primary tracheal anastomosis should be considered as an important treatment option for severe subglottic stenoses in infants and children.

Entities:  

Mesh:

Year:  1993        PMID: 8231582     DOI: 10.1288/00005537-199311000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

1.  [Paediatric laryngotracheal stenosis: pattern of care in Germany].

Authors:  C Sittel; T Buckel; I Baumann; P K Plinkert
Journal:  HNO       Date:  2006-12       Impact factor: 1.284

Review 2.  [Pediatric respiratory tract stenoses: are subspecialization and the development of specialist centers necessary?].

Authors:  G Friedrich
Journal:  HNO       Date:  2006-12       Impact factor: 1.284

3.  Laryngotracheal reconstruction using iliac crest graft: an institutional experience.

Authors:  Kranti Bhavana; Isha Tyagi; Mukesh Kumar Ramani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

4.  Surgical management of laryngotracheal stenosis in adults.

Authors:  Mercy George; Florian Lang; Philippe Pasche; Philippe Monnier
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-01-25       Impact factor: 2.503

5.  Experimental validation of laryngotracheal growth and recurrent laryngeal nerve preservation after partial cricotracheal resection in a growing rabbit model.

Authors:  Keiichi Morita; Kosaku Maeda; Insu Kawahara; Yuko Bitoh
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

6.  [The risks of autogenous cartilage grafting in laryngotracheal reconstruction in adults].

Authors:  H-J Schultz-Coulon; T Stange; A Neumann
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

7.  [Subglottic stenosis in the first year of life. Characteristics and treatment options].

Authors:  C Sittel
Journal:  HNO       Date:  2012-07       Impact factor: 1.284

8.  Fetal cricotracheal manipulation: effects on airway healing, cricoid growth and lung development.

Authors:  Guido Ciprandi; Richard Nicollas; Jean Michel Triglia; Massimo Rivosecchi
Journal:  Pediatr Surg Int       Date:  2003-07-18       Impact factor: 1.827

9.  Thermoforming of tracheal cartilage: viability, shape change, and mechanical behavior.

Authors:  Yongseok Chae; Dmitriy Protsenko; Paul K Holden; Cara Chlebicki; Brian J F Wong
Journal:  Lasers Surg Med       Date:  2008-10       Impact factor: 4.025

10.  [The management of postintubation stenoses in children].

Authors:  H-J Schultz-Coulon
Journal:  HNO       Date:  2004-04       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.